- Home
- ATER vs BOLT Comparison
ATER vs BOLT Comparison
Compare ATER & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- BOLT
- Stock Information
- Founded
- ATER 2014
- BOLT 2015
- Country
- ATER United States
- BOLT United States
- Employees
- ATER N/A
- BOLT N/A
- Industry
- ATER Home Furnishings
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- ATER Consumer Discretionary
- BOLT Health Care
- Exchange
- ATER Nasdaq
- BOLT Nasdaq
- Market Cap
- ATER 10.4M
- BOLT 9.4M
- IPO Year
- ATER N/A
- BOLT 2021
- Fundamental
- Price
- ATER $0.98
- BOLT $5.19
- Analyst Decision
- ATER
- BOLT Buy
- Analyst Count
- ATER 0
- BOLT 3
- Target Price
- ATER N/A
- BOLT $47.50
- AVG Volume (30 Days)
- ATER 121.7K
- BOLT 14.4K
- Earning Date
- ATER 08-13-2025
- BOLT 08-14-2025
- Dividend Yield
- ATER N/A
- BOLT N/A
- EPS Growth
- ATER N/A
- BOLT N/A
- EPS
- ATER N/A
- BOLT N/A
- Revenue
- ATER $85,668,000.00
- BOLT $4,167,000.00
- Revenue This Year
- ATER N/A
- BOLT N/A
- Revenue Next Year
- ATER $7.48
- BOLT N/A
- P/E Ratio
- ATER N/A
- BOLT N/A
- Revenue Growth
- ATER N/A
- BOLT N/A
- 52 Week Low
- ATER $0.90
- BOLT $4.59
- 52 Week High
- ATER $3.84
- BOLT $14.36
- Technical
- Relative Strength Index (RSI)
- ATER 36.18
- BOLT 46.64
- Support Level
- ATER $0.94
- BOLT $4.81
- Resistance Level
- ATER $1.07
- BOLT $5.28
- Average True Range (ATR)
- ATER 0.05
- BOLT 0.26
- MACD
- ATER 0.01
- BOLT 0.01
- Stochastic Oscillator
- ATER 33.41
- BOLT 70.26
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.